Funded Tech Companies
Bridge Medicines
Bridge Medicines, operating out of New York, received equity investments through private investors.
Company Overview
Company Name
Bridge Medicines
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
780 3rd Ave.
New York, NY 10017
USA
New York, NY 10017
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Bridge Medicines is a drug discovery company launched in partnership with Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine, Takeda Pharmaceutical Company Ltd. and healthcare investment firms Bay City Capital and Deerfield Management.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/16/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Carl Goldfischer
Chief Executive Officer
William Polvino
Chief Scientific Officer
Louis Renzetti
Company Investors
Browse more funded tech companies:
Bridge Laboratories | Bridge Money
Share this article
About Our VC & M&A Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs